References
-
1) Mechanism of pachymic acid in the treatment of gastric cancer based on network pharmacology and experimental verification.
-
2) Investigation of the underlying mechanism of Buyang Huanwu decoction in ischemic stroke by integrating systems pharmacology-proteomics and in vivo experiments.
-
3) Rapamycin mitigates organ damage by autophagy-mediated NLRP3 inflammasome inactivation in sepsis.
-
4) Mucosa‑associated lymphoid tissue lymphoma translocation protein 1 inhibitor, MI‑2, attenuates non‑small cell lung cancer cell proliferation, migration and invasion, and promotes apoptosis by suppressing the JNK/c‑JUN pathway.
-
5) PCK2 induces gefitinib resistance by suppresses ferroptosis in non-small cell lung cancer.
-
6) Akkermansia muciniphila improves gastric cancer treatment by modulating the immune microenvironment.
-
7) Analysis of metastasis‑related risk factors and clinical relevance in adult soft‑tissue sarcoma.
-
8) Exploring the role of iNOS in HFpEF-Related myocardial fibrosis: Involvement of PTEN-PI3K/AKT signaling pathway.
-
9) MTCH2 promotes the malignant progression of ovarian cancer through the upregulation of AIMP2 expression levels, mitochondrial dysfunction and by mediating energy metabolism.
-
10) Tranilast alleviates skin inflammation and fibrosis in rosacea-like mice induced by long-term exposure to LL-37.
-
11) Targeting colorectal cancer with Herba Patriniae and Coix seed: Network pharmacology, molecular docking, and in vitro validation.
-
12) Interaction between miR‑206 and lncRNA MALAT1 in regulating viability and invasion in hepatocellular carcinoma.
-
13) Electroacupuncture prevents the development or establishment of chronic pain via IL-33/ST2 signaling in hyperalgesic priming model rats.
-
14) The effects of noise exposure on hippocampal cognition in C57BL/6 mice via transcriptomics.
-
15) 7,8-Dihydroxyflavone ameliorates cognitive impairment induced by repeated neonatal sevoflurane exposures in mice through increasing tau O-GlcNAcylation.